Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
25 participants
OBSERVATIONAL
2021-02-01
2026-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Phage Safety Cohort Study
NCT04650607
Bacteriophage Therapy in Patients With Prosthetic Joint Infections (PJI)
NCT05269134
Bacteriophage Therapy in First Time Chronic Prosthetic Joint Infections
NCT05269121
Phage Therapy for the Treatment of a Chronic Enterococcus Faecium Periprosthetic Joint Infection
NCT06942624
Use of Phage Therapy for Treatment of a Periprosthetic Joint Infection
NCT06827041
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
patients having had avderse event after phagotherapy for bone or joint infection
patients having had avderse event after phagotherapy for bone or joint or implant infection
to determine the accountability of adverse effects in having had avderse event after phagotherapy for bone or joint or implant infection
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
patients having had avderse event after phagotherapy for bone or joint or implant infection
to determine the accountability of adverse effects in having had avderse event after phagotherapy for bone or joint or implant infection
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospices Civils de Lyon
Lyon, , France
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Related Links
Access external resources that provide additional context or updates about the study.
Related Info
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
334
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.